MET and glioblastoma: Simultaneous targeting of the VEGF and c-MET pathways may therefore be an interesting therapeutic approach for c-MET-positive glioblastoma because it will reduce vessel leakage (resulting in edema reduction) and simultaneously may reduce tumor cell migration and thus tumor progression.